The second 'Yuan Ming Kangde Life Chemistry Research Award' was reviewed

In China and the United States, there are operating entities, and the world's leading pharmaceutical, biopharmaceutical and medical device R&D services company WuXi PharmaTech (NYSE:) announced today that the second "Pharmaceutical Medicine Research Award" was completed. The award ceremony will be held in the Great Hall of the People on December 7th.
In 2008, the second “Pharmaceutical Medicine Research Award” was in the field of preclinical pharmacology and toxicology. Academician Sang Guowei, deputy director of the Education, Culture, and Health Committee of the Standing Committee of the National People's Congress, served as the chairman of the Standing Committee of the current session. Members of the judging panel include Director of Chengdu Chinese Medicine Safety Evaluation Center, Professor Wang Li of Sichuan University, Li Bo, Director of National Drug Safety Evaluation and Monitoring Center, CEO of WuXi PharmaTech New Drug Development Co., Ltd., and Associate Professor of Tongji University, Li Ge, Department of Science and Technology, Academy of Military Medical Sciences Zhang Yongxiang, deputy director and researcher of the Institute of Toxic Drugs, Chen Kaixian, president of Shanghai University of Traditional Chinese Medicine, academician of the Chinese Academy of Sciences, Chen Yuhui, research director of WuXi PharmaTech New Drug Development Co., Ltd., and part-time professor of Tongji University, researcher of Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, and Lin Guoqiang, academician of Chinese Academy of Sciences Professor of Central South University, Academician of the Chinese Academy of Engineering Zhou Hongyi, Director of QA of the New Drug Safety Evaluation Center of the Second Military Medical University, Professor Yuan Bojun, and Director of the New Drug Safety Evaluation Center of the Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, QA Director and Professor Liao Mingyang.
The “Pharmaceutical Kanto Life Chemistry Research Awards 2008” selection campaign kicked off in July this year. During the evaluation process, dozens of papers were selected. After the judges’ serious, intense and orderly selection, 12 winners were selected. The results will be announced on December 7, 2008 at the Great Hall of the People in Beijing. At that time, the leaders of the Ministry of Science and Technology and the Ministry of Commerce will visit the site to present awards to the winners.
The selection of the “Wu Ming Kang De Life Chemistry Research Award 2008” was strongly supported by the Tianjin Economic and Technological Development Zone and Suzhou Wuzhong District. At that time, any member of the Management Committee of Tianjin Economic and Technological Development Zone, Shushan, and Jin Hailong, Secretary of the Wuzhong District Party Committee of Suzhou, will also be present at the awarding ceremony to commend 12 young scientists and technicians for their efforts in the biomedical cause.
As the pharmaceutical research and development service provider of China's Lingxian, WuXi PharmaTech has promoted scientific and technological talents in related fields by holding the "Pharmaceutical Medicine Research Award", which has aroused the society's chemistry, life science, medicine, pharmacy and related fields. Wide attention, so as to promote the scientific and technological progress and industrial development in the field of life chemistry in China.
About WuXi PharmaTech
WuXi PharmaTech, headquartered in Shanghai, China and operating in the United States and China, is the world's leading pharmaceutical, biotechnology and medical device R&D outsourcing services company. As a research-focused, customer-focused company, WuXi PharmaTech provides a full range of laboratory R&D, research and production, biologics testing and production services to global pharmaceutical companies, biotechnology companies and medical device companies. The scope runs through the entire process of pharmaceutical and medical device development. WuXi PharmaTech's services are designed to help its global partners reduce drug and medical device development cycles and reduce research and development costs. The operating subsidiary of WuXiPharmaTech is called WuXiAppTec.

Yingmed offers a wide variety of laboratory devices for timely examination of patient samples. In addition to high-quality lab devices like Centrifuge And Mixer, Microscopes, Trisection Fully Auto Hematology Analyzer, Urine Analyzer, you will also find the compatible laboratory accessories, including test strips, Test tubes, Vacuum Blood Collection Tube, Electronic Pipette, Pipette Tips , Petri Dishes, Embedding Cassettes.

Medical Lab Devices

Medical Lab Devices,Lab Equipment,Laboratory Equipment,Medical Laboratory Equipment,Lab Consumable Products

NINGBO YINGMED MEDICAL INSTRUMENTS CO.,LTD , https://www.chinayingmed.com

Posted on